Global Inferior Vena Cava Filter Market Report and Forecast 2024-2032

Inferior Vena Cava Filter Market Size 

The global inferior vena cava filter market was valued at USD 805.39 million in 2023 due to the increasing incidence of deep vein thrombosis across the globe. The market is expected to grow at a CAGR of 9.10% during the forecast period 2024-2032 and attain a market value of USD 1763.86 million by 2032.

Inferior Vena Cava Filter Market Outlook

• The market value for inferior vena cava filters is driven by the rising cases of venous thromboembolism, and improvements in filter design.

• One of the major market trends includes increasing emphasis on the safety and efficacy of inferior vena cava filters.

• North America is expected to dominate the market driven by elevated healthcare expenditures, sophisticated medical facilities, and rising awareness of preventive healthcare.

Global Inferior Vena Cava Filter Market Overview

An inferior vena cava filter also known as an IVC filter is a medical device which is inserted in the inferior vena cava to prevent the blood clots from moving to the lungs. The IVC is a blood vessel that transports oxygen-poor blood from the lower body to the heart. There are various types of IVC filters based on their design and function. These are permanent, retrievable, or temporary filters. Permanent filters are used for long-term protection whereas retrievable filters are removable once the risk subsides. Temporary filters are short-term and taken out following the completion of treatment. These filters are customized for each patient to help avoid clotting in those who cannot use blood thinners or have temporary risk factors.

IVC filter placement is a minimal invasion method. It is done by inserting these filters through a catheter in a vein, usually in the groin or neck. Imaging techniques such as fluoroscopy or ultrasound are used to place them in the inferior vena cava accurately.

Inferior Vena Cava Filter Market Growth Drivers

Rising Deep Vein Thrombosis Prevalence Boosts the Market Significantly

Due to the rising prevalence of deep vein thrombosis (DVT), the global market for inferior vena cava (IVC) filters is also growing. DVT is a condition of blood clot formation in a vein of the leg. According to a study published in 2023, DVT occurs at a rate of 1.6 per 1000 people each year. These rates depend on the different locations such as distal veins, femoral, common femoral, popliteal, and veins. DVTs can occur when a person is immobile for long time periods. People with medical issues such as cancer or an inherited blood disease that is associated with clotting can also experience DVT. Factors like aging population, sedentary lifestyles, obesity, and chronic diseases contribute to the increase in DVT cases and require necessitating preventive measures. IVC filters are implanted in the inferior vena cava to capture the blood clots and prevent complications.

Application of IVC Filters in the Prevention of Pulmonary Embolism to Boost the Global Inferior Vena Cava Filter Market Demand

IVC filters are crucial in the treatment of pulmonary embolisms, a condition in which there are blood clots in the lungs that obstruct blood flow and oxygen levels. IVC interruption devices are essential in stopping bigger pulmonary embolisms that come from the venous system beyond the site where the device is implanted. They serve as a compromise by capturing all clots while keeping the IVC open. Immediate diagnosis and treatment are essential. Generally, low-risk patients are treated with Direct Oral Anticoagulants (DOACs) and discharged, whereas intermediate- and high-risk patients require more intensive treatments such as thrombolysis, thrombectomy, and IVC filters. The rising demand for IVC filters in the global market is driven by the growing popularity of minimally invasive techniques and advancements in healthcare facilities, underscoring the crucial role of these filters in managing PE.

Inferior Vena Cava Filter Market Trends

The market is witnessing several trends and developments to improve the current scenario. Some of the notable trends are as follows:

Technological Advancements

Improved filter designs, materials compatible with the body, and less invasive implantation techniques have increased the appeal of IVC filters for patients and medical professionals. Enhanced imaging technologies and digital health tools are increasing the accuracy of filter placement, patient monitoring, and interventions. These innovations enhance the functionality and safety of IVC filters while also broadening their uses to meet changing healthcare demands and improve patient treatment.

Growing Elderly Population

The elderly population, who are at higher risk for chronic diseases such as heart disease and limited movement, are more vulnerable to venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and pulmonary embolism (PE). The demand for IVC filters is increasing as it is being used for preventive measures. The increased demand is prompting healthcare providers and manufacturers to create more specialized filters for the specific requirements of older patients.

Increased Focus on Safety and Efficacy

Concerns about complications like filter migration, perforation, and thrombosis are driving significant innovation and regulatory scrutiny in the market. Manufacturers are putting efforts into advanced materials and design enhancements, such as retrievable filters and increased clot-trapping effectiveness. Regulatory authorities are also implementing more stringent criteria for clinical trials and monitoring after products to guarantee sustained safety and effectiveness.

Increasing Awareness About the Condition

Healthcare professionals and individuals are gaining an increased understanding of the advantages of IVC filters, which results in a stronger emphasis on education and training. Patients are getting educated on the risks of DVT and PE, while professionals are being provided with improved training on insertion and management. Regulatory authorities are also encouraging the safe use of IVC filters. This increased level of awareness is enhancing patient safety, fueling market expansion, and guaranteeing that both patients and healthcare professionals are making informed choices about the utilization of IVC filters.

Inferior Vena Cava Filter Market Segmentation

Market Breakup by Product Type

• Retrieval

• Permanent

• Others

Market Breakup by Application

• Treatment of Venous Thromboembolism

• Prevention of Pulmonary Embolism

• Others

Market Breakup by Material

• Non-Ferromagnetic Material

• Ferromagnetic Materials

Market Breakup by End User

• Hospitals

• Ambulatory Surgical Centers

• Others

Market Breakup by Region

• North America

• Europe

• Asia Pacific

• Latin America

• Middle East and Africa

Inferior Vena Cava Filter Market Share

Market Share Based on Product Type to Witness Growth

The market is segmented into retrieval, permanent, and others based on the product type. Among them, the retrieval type is expected to lead the market. Retrieved filters are the filters that can be removed once the risk level goes down, this helps in decreasing the complications. They provide temporary shelter in dangerous situations and are removable once they are no longer necessary. Retrievable filters are popular because of their versatility and reduced risk, resulting in widespread use in the market.

Market Segmentation on the Basis of Material

Based on material, the market is divided into non-ferromagnetic and ferromagnetic materials. Non-ferromagnetic material is expected to lead the market during the forecast years as it does not contain iron which can interfere with magnetic resonance imaging (MRI) and other diagnostic procedures.

Filters made up of non-ferromagnetic materials such as titanium and stainless steel are frequently utilized in IVC filters due to their safety and compatibility. Titanium is chosen for its biocompatibility, lightweight, and resistance to corrosion, while stainless steel provides strength, flexibility, and durability at a more affordable price. Both substances are efficient in prevention of blood clots with low chances of complications.

Inferior Vena Cava Filter Market Analysis by Region

Based on region, the market report covers North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. North America is expected to dominate the market in the forecast period.

The growth of the North American IVC filter market is driven by elevated healthcare expenditures, sophisticated medical facilities, and rising awareness of preventive healthcare. The United States plays a significant role with a substantial number of patients impacted by cardiovascular diseases, DVT, and PE. Positive reimbursement policies and government initiatives in VTE prevention are also contributing to the increase.

Europe is also poised to have a significant market share propelled by robust healthcare systems and a rising prevalence of cardiovascular diseases. Germany, France, and the United Kingdom are at the forefront with sophisticated infrastructure and significant healthcare investment. The market in the Asia-Pacific region is expanding rapidly which is fueled by the rising prevalence of cardiovascular diseases and aging populations, with China, Japan, and India playing significant roles. Growing knowledge about VTE, economic growth, government efforts, technological progress, and partnerships are broadening market prospects.

Leading Players in the Inferior Vena Cava Filter Market

The key features of the market report include patent analysis, grant analysis, funding, and investment analysis as well as recent partnerships and collaborations by the leading players. The major companies in the market are as follows:

Adient Medical Inc.

Adient is developing absorbable medical devices that safely dissolve in the body once they are no longer needed. It was established in 2012. They concentrate on creating devices that remain effective until they naturally disappear, reducing the necessity for removal operations. In 2022 cordis-X, which is a global frontrunner in the innovation and production of interventional cardiovascular technologies, invested in Adient for their fully absorbable IVC filter, which offers protection against pulmonary embolisms.

Becton, Dickinson and Company

Becton, Dickinson and Company also called as BD, is a U.S.-based multinational corporation specializing in producing and distributing medical equipment, tools, and chemicals. It was established in 1897 with headquarters located in New Jersey, United States. One of the biggest medical technology companies globally, it is enhancing healthcare access worldwide through advancements in medical research, diagnostics, and patient treatment.

Argon Medical

Argon Medical is a top worldwide producer of specialized medical items. It was established in 1972 and has its headquarters in Plano, Texas. They provide a diverse selection of medical equipment for different medical specialities such as interventional radiology, vascular surgery, interventional cardiology, and oncology. The company has a major role in IVC filters  and created the Single-Loop and Triple-Loop Retrieval Kits for percutaneous extraction of retrievable inferior vena cava filters through a jugular approach. These kits have a coil-reinforced outer sheath, radiopaque bands for better visibility, and a curved tip for precise control during retrieval.

Cardinal Health

Cardinal Health is a multinational healthcare services company based in the United States that was established in 1971. Based in Ohio, United States, the company focuses on pharmaceutical distribution, manufacturing medical products, and running a vast network of radiopharmacies across the United States.

Other players in the market include ALN, B. Braun Melsungen AG, Braile Biomedica, Cook Medical, Cordis, and Volcano Corporation.

Key Highlights of the Report

Key Questions Answered in the Inferior Vena Cava Filter Market Report

• What was the global inferior vena cava filter market value in 2023? 
• What is the global inferior vena cava filter market forecast outlook for 2024-2032? 
• What are the regional markets covered in the EMR report?
• What is market segmentation based on product type? 
• What is market breakup based on application?
• What is market segmentation based on material?
• What are the major end users in the market? 
• What are the major factors aiding the global inferior vena cava filter market demand? 
• How has the market performed so far and how is it anticipated to perform in the coming years? 
• What are the major drivers, opportunities, and restraints in the market?  
• What are the major trends influencing the market?  
• Which country is likely to experience elevated growth during the forecast period?  
• Which regional market is expected to dominate the market share in the forecast period?  
• Who are the key players involved in the global inferior vena cava filter market? 
• What are the current unmet needs and challenges in the market? 
• How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?